Blood Safety

Study Findings Result in Deferment of Donors with Medium Risk for HIV

Published in Blood Weekly, December 7th, 2000

Testing of potential blood donors classified as "medium risk" revealed four with anti-HIV antibodies at a center in Italy. As a result, health officials with the Centro Trasfusionale e di Immunologia dei Trapianti in Milan said they will continue to defer medium risk donors.

They recently reported the findings of their longitudinal, prospective study in the journal Haematologica (C. Silvani et al., "Blood donors with 'medium' or 'minor' risk factors for human immunodeficiency virus infection: Are they eligible for donation'" Haematologica, 2000;85(10):1055-1059).

Over four years, C. Silvani and coworkers collected psychosocial and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2000-12-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry